Literature DB >> 606307

Nabilone: a potent antiemetic cannabinol with minimal euphoria.

T S Herman, S E Jones, J Dean, S Leigh, R Dorr, T E Moon, S E Salmon.   

Abstract

Nabilone is a cannabinol derivative which has potent central antiemetic effects in animals. We observed that the drug significantly reduced the nausea and vomiting induced by cancer chemotherapy in 10 of 13 patients who were refractory to conventional antiemetics. A dose-response effect was apparent. The drug was generally well-tolerated, although it also had sedative effects. Additionally, dizziness, decreased coordination and postural hypotension were observed in some patients. Euphoric effects of the agent were minimal at antiemetic dosage levels.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 606307

Source DB:  PubMed          Journal:  Biomedicine        ISSN: 0300-0893


  8 in total

1.  Cancer chemotherapy--the inbuilt deterrent.

Authors: 
Journal:  Br Med J       Date:  1979-11-24

2.  Constituents of Cannabis Sativa.

Authors:  Erin M Rock; Linda A Parker
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Microbiological transformations of nabilone, a synthetic cannabinoid.

Authors:  R A Archer; D S Fukuda; A D Kossoy; B J Abbott
Journal:  Appl Environ Microbiol       Date:  1979-05       Impact factor: 4.792

Review 4.  Nabilone. A preliminary review of its pharmacological properties and therapeutic use.

Authors:  A Ward; B Holmes
Journal:  Drugs       Date:  1985-08       Impact factor: 9.546

5.  Reinforcing properties of oral delta 9-tetrahydrocannabinol, smoked marijuana, and nabilone: influence of previous marijuana use.

Authors:  J H Mendelson; N K Mello
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

6.  Review of cannabinoids and their antiemetic effectiveness.

Authors:  B J Vincent; D J McQuiston; L H Einhorn; C M Nagy; M J Brames
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

7.  A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting.

Authors:  Mark A Ware; Paul Daeninck; Vincent Maida
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

Review 8.  Cannabinoid Regulation of Acute and Anticipatory Nausea.

Authors:  Erin M Rock; Martin A Sticht; Cheryl L Limebeer; Linda A Parker
Journal:  Cannabis Cannabinoid Res       Date:  2016-04-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.